Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Nature Reviews. Cancer|May 6, 2018
Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapyKwame Twumasi-Boateng, Jessica L Pettigrew, Y Y Eunice Kwok, et al.
Analytical Chemistry|February 7, 2012
Aptamer-based viability impedimetric sensor for virusesMahmoud Labib, Anna S Zamay, Darija Muharemagic, et al.
Cytokine & Growth Factor Reviews|July 29, 2020
Engineering and combining oncolytic measles virus for cancer therapyMathias F Leber, Serge Neault, Elise Jirovec, et al.
Annals of Surgical Oncology|July 19, 2012
Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experienceJohn C Bell, Barnaby G Rylah, Robert W Chambers, et al.
Scientific Reports|July 13, 2017
Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer CellsAlan Morettin, Geneviève Paris, Younes Bouzid, et al.
Molecular Therapy. Nucleic Acids|June 4, 2014
Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing AntibodiesDarija Muharemagic, Anna Zamay, Shahrokh M Ghobadloo, et al.
Nature Protocols|May 20, 2024
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapyShashi Gujar, Jonathan G Pol, Vishnupriyan Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapyMichelle Cronin, Fabrice Le Boeuf, Carola Murphy, et al.
International Journal of Cancer|December 17, 2011
Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infectionFabrice Le Boeuf, Nima Niknejad, Jiahu Wang, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Nature Reviews. Cancer|May 6, 2018
Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapyKwame Twumasi-Boateng, Jessica L Pettigrew, Y Y Eunice Kwok, et al.
Analytical Chemistry|February 7, 2012
Aptamer-based viability impedimetric sensor for virusesMahmoud Labib, Anna S Zamay, Darija Muharemagic, et al.
Cytokine & Growth Factor Reviews|July 29, 2020
Engineering and combining oncolytic measles virus for cancer therapyMathias F Leber, Serge Neault, Elise Jirovec, et al.
Annals of Surgical Oncology|July 19, 2012
Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experienceJohn C Bell, Barnaby G Rylah, Robert W Chambers, et al.
Scientific Reports|July 13, 2017
Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer CellsAlan Morettin, Geneviève Paris, Younes Bouzid, et al.
Molecular Therapy. Nucleic Acids|June 4, 2014
Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing AntibodiesDarija Muharemagic, Anna Zamay, Shahrokh M Ghobadloo, et al.
Nature Protocols|May 20, 2024
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapyShashi Gujar, Jonathan G Pol, Vishnupriyan Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2008
A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replicationRobert E Edge, Theresa J Falls, Christopher W Brown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapyMichelle Cronin, Fabrice Le Boeuf, Carola Murphy, et al.
International Journal of Cancer|December 17, 2011
Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infectionFabrice Le Boeuf, Nima Niknejad, Jiahu Wang, et al.
Pageof 20